Lactate predicts 90-day acute-on-chronic liver failure in acute decompensated cirrhosis: A retrospective cohort study
Abstract Background & Aims Existing prognostic models demonstrate insufficient sensitivity in predicting acute-on-chronic liver failure (ACLF) among patients with cirrhosis experiencing acute decompensation (AD). We postulated that serum lactate levels, indicative of systemic metabolic dysregulation, could enhance the stratification of ACLF risk. Methods This retrospective cohort study included 831 hospitalized patients with AD from The Second Hospital of Nanjing, spanning the years 2015 to 2024. Serum lactate levels were assessed upon admission. The primary outcome was the development of ACLF, as defined by the EASL-CLIF criteria, within a 90-day period. Multivariable Cox regression, receiver operating characteristic (ROC) analysis, and competing risk models were employed to evaluate the prognostic significance of lactate levels and to establish an optimal threshold. A nomogram was subsequently developed and subjected to internal validation. Results ACLF developed in 272/831 (32.7%) patients. ACLF patients had higher lactate (median 4.6 vs 3.5 mmol/L, p<0.001). Each 1-mmol/L lactate increase independently predicted ACLF risk (HR 1.16, 95% CI 1.10–1.22). A lactate threshold of 4.8 mmol/L stratified high-risk patients (sensitivity 47.8%, specificity 72.8%). A nomogram integrating lactate, infection, INR, bilirubin, and creatinine outperformed traditional models (AUC 0.783 vs MELD 0.701). Results remained robust in competing risk analyses (sHR 1.15, 95% CI 1.07–1.23). Conclusions Lactate is an independent predictor of 90-day ACLF in AD cirrhosis. A cut-off of 4.8 mmol/L enhances risk stratification, and lactate-integrated models improve prognostic accuracy. Routine lactate measurement may guide early intervention.
Authors
- 杨永峰
- Ruiqi Li (ORCID: https://orcid.org/0000-0003-1171-8168)
- Changhua Yi (ORCID: https://orcid.org/0009-0008-2154-1662)
- Jun Guo (ORCID: https://orcid.org/0000-0002-8525-8267)
- Xixuan Wang (ORCID: https://orcid.org/0000-0003-3564-7616)
- Shuling Chen (ORCID: https://orcid.org/0000-0002-3167-5532)
- Qingfang Xiong (ORCID: https://orcid.org/0000-0003-2743-555X)
- Xiaoying Dong
- Jiale Shen
- Caiyun Zhang
- Hongli Liu
- Hao Ren
Institutions
- Nanjing University of Chinese Medicine (CN)
- Southeast University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11313343/v1
- Primary Topic
- Liver Disease and Transplantation
- Type
- preprint
Funders
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province